- Home
- MNPR vs FOXF Comparison
MNPR vs FOXF Comparison
Compare MNPR & FOXF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNPR | FOXF |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Motor Vehicles |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 531.6M | 618.2M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | MNPR | FOXF |
|---|---|---|
| Price | $70.61 | $17.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 5 |
| Target Price | ★ $97.83 | $33.00 |
| AVG Volume (30 Days) | 191.8K | ★ 988.2K |
| Earning Date | 11-13-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,459,086,000.00 |
| Revenue This Year | N/A | $6.82 |
| Revenue Next Year | N/A | $3.76 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $21.00 | $13.08 |
| 52 Week High | $105.00 | $31.18 |
Technical Indicators
Market Signals| Indicator | MNPR | FOXF |
|---|---|---|
| Relative Strength Index (RSI) | 41.11 | 55.21 |
| Support Level | $64.25 | $16.93 |
| Resistance Level | $74.34 | $17.85 |
| Average True Range (ATR) | 4.79 | 0.62 |
| MACD | -0.53 | 0.31 |
| Stochastic Oscillator | 31.45 | 85.84 |
Price Performance
Historical ComparisonAbout MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About FOXF Fox Factory Holding Corp.
Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World.